← Back to Search

Camu Camu Capsules for Human Immunodeficiency Virus Infection

Phase 1
Waitlist Available
Led By Jean-Pierre Routy, MD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks and 20 weeks
Awards & highlights

Study Summary

This trial will investigate if a natural product can help people with HIV by reducing inflammation and risks of obesity, diabetes and cardiovascular diseases.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks and 20 wekks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks and 20 wekks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction of the plasma marker of microbial translocation LPS, assessed using ELISA.
Secondary outcome measures
Association between baseline gut microbiota composition (16S rDNA sequencing), and markers of gut integrity (I-FABP, tissue staining) and inflammation (T-cell activation, inflammatory cytokines).
Changes in A. muciniphila levels in stools using qPCR
Changes in HIV reservoir size in biopsies using qPCR
+10 more
Other outcome measures
Biopsy
Exploratory: Difference in HIV reservoir size from Baseline (Visit 0) to 12 weeks post-CC treatment by TILDA, performed on blood samples

Trial Design

1Treatment groups
Experimental Treatment
Group I: Camu CamuExperimental Treatment1 Intervention
Assessments will be done at baseline, during and after 12 weeks of Camu Camu intake.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Camu Camu Capsules
2020
Completed Phase 1
~30

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
452 Previous Clinical Trials
161,870 Total Patients Enrolled
Jean-Pierre Routy, MDPrincipal InvestigatorMcGill University Health Centre/Research Institute of the McGill University Health Centre
3 Previous Clinical Trials
119 Total Patients Enrolled
~5 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top